Terminal deoxynucleotidyl transferase activity in blastic phase of chronic myelogenous leukemia.
D000328:Adult; D004254:DNA Nucleotidyltransferases / Q000378:metabolism*; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D014750:Vincristine; D004254:DNA Nucleotidyltransferases; D004259:DNA-Directed DNA Polymerase; D011241:Prednisone